Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced the launch of Vigadrone™ (vigabatrin) for Oral Solution, 500 mg, a fully substitutable, AA-rated generic version of Sabril® (vigabatrin) powder for oral solution.
Novaliq GmbH, a specialty pharmaceutical company with the first water-free technology platform that transforms poorly soluble drugs into effective therapeutics for ophthalmology, announced that NovaTears®, a novel topical treatment of dry eye disease (DED) and meibomian gland dysfunction (MGD), is now also available in Australia.
Synaptive Medical Inc., a Toronto-based medical technology company, today announced that Duke University Medical Center has acquired its connected neurosurgery system. Modus V™, the cornerstone of the company’s automated robotic and imaging technology, sets the new standard for visual accuracy during surgery and advances minimally invasive cranial and spine procedures.
The Carl R. Woese Institute for Genomic Biology (IGB) at the University of Illinois at Urbana-Champaign has purchased an EnvisionTEC 3D-Bioplotter to conduct regenerative biology and tissue engineering research.
A new benchtop instrument from Thermo Fisher Scientific, the Phadia 200, enables new levels of flexibility and automation for laboratory testing facilities to aid in the diagnosis of allergy and autoimmunity conditions. The Phadia 200 is CE-marked, and the first installations are underway at select European sites.